XML 17 R16.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

STOCK OPTIONS AND AWARDS | 12 Months Ended
--- | ---
Dec. 28, 2019
Stock Options and Awards [Abstract] |
Stock Options and Awards | 7. S tock O ptions and A wards Stock Options As of December 28, 2019, the Company had one stock option plan, The Eastern Company 2010 Executive Stock Incentive Plan (the “2010 Plan”), for officers, other key employees, and non-employee Directors. Incentive stock options granted under the 2010 Plan must have exercise prices that are not less than 100% of the fair market value of the Company’s common stock on the dates the stock options are granted. Restricted stock awards may also be granted to participants under the 2010 Plan with restrictions determined by the Compensation Committee of the Company’s Board of Directors. Under the 2010 Plan, non-qualified stock options granted to participants will have exercise prices determined by the Compensation Committee of the Company’s Board of Directors. During 2019 and 2018, no stock options or restricted stock were granted that were subject to the meeting of performance measurements. For the period of 2019, the Company used several assumptions which included an expected term of 3.5 to 4 years, volatility deviation of 28.88% and 32.33% and a risk free rate of 1.42% to 2.48%. For the period of 2018, the Company used several assumptions which included an expected term of 3.5 years, volatility deviation of 29.5% and a risk free rate of 2.33%. The 2010 Plan also permits the issuance of Stock Appreciation Rights (“SARs”). The SARs are in the form of an option with a cashless exercise price equal to the difference between the fair value of the Company’s common stock at the date of grant and the fair value as of the exercise date resulting in the issuance of the Company’s common stock. During 2019, the Company issued 96,000 SARs and during 2018 51,000 SARs were issued. Stock-based compensation expense in connection with SARs granted to employees during fiscal year 2019 was $397,250 and for 2018 was $276,778. As of December 28, 2019, there were 178,500 shares of common stock reserved and available for future grant under the above noted 2010 Plan. The following tables set forth the outstanding SARs for the period specified:
|  | Year Ended December 28,2019 |  |  | Year Ended December 29, 2018 |
|  | Units |  |  | Weighted - Average Exercise Price |  |  | Units |  |  | Weighted - Average Exercise Price |
Outstanding at beginning of period |  |  | 189,167 |  |  | $ | 21.46 |  |  |  | 141,500 |  |  | $ | 20.36 |
Issued |  |  | 96,000 |  |  |  | 23.65 |  |  |  | 51,000 |  |  |  | 24.90 |
Exercised |  |  | (1,667 | ) |  |  | 19.10 |  |  |  | — |  |  |  | — |
Forfeited |  |  | (7,500 | ) |  |  | 21.20 |  |  |  | (3,333 | ) |  |  | 19.10 |
Outstanding at end of period |  |  | 276,000 |  |  |  | 22.30 |  |  |  | 189,167 |  |  |  | 21.46 |
SARs Outstanding and Exercisable |
Range of Exercise Prices |  |  | Outstanding as of December 28,2019 |  |  | Weighted- Average Remaining Contractual Life |  |  | Weighted- Average Exercise Price |  |  | Exercisable as of December 28, 2019 |  |  | Weighted- Average Remaining Contractual Life |  |  | Weighted- Average Exercise Price |
$ | 19.10-26.30 |  |  |  | 276,000 |  |  |  | 3.3 |  |  | $ | 22.30 |  |  |  | 38,003 |  |  |  | 2.3 |  |  |  | 19.10 |
The following tables set forth the outstanding stock grants for the period specified:
|  | Year Ended December 28,2019 |  |  | Year Ended December 29, 2018 |
|  | Shares |  |  | Weighted - Average Exercise Price |  |  | Shares |  |  | Weighted - Average Exercise Price |
Outstanding at beginning of period |  |  | 25,000 |  |  | $ | — |  |  |  | 25,000 |  |  | $ | — |
Issued |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding at end of period |  |  | 25,000 |  |  |  | — |  |  |  | 25,000 |  |  |  | — |
Stock Grants Outstanding and Exercisable |
Range of Exercise Prices |  |  | Outstanding as of December 28, 2019 |  |  | Weighted- Average Remaining Contractual Life |  |  | Weighted- Average Exercise Price |  |  | Exercisable as of December 28, 2019 |  |  | Weighted- Average Remaining Contractual Life |  |  | Weighted- Average Exercise Price |
$ | 0.00 |  |  |  | 25,000 |  |  |  | 2.3 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
As of December 28, 2019, outstanding SARs and options had an intrinsic value of $2,898,945.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration